HDAC9 and breast carcinoma: Taken together, cell-based and MD simulations suggested tetracosanedioic acid and other long-chain FFAs as inhibitors of HDAC, which may account for intracellular effects leading to antiproliferative and proapoptotic effects in breast cancer cells.